Nivolumab versus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer

BACKGROUND: Options for patients with non-squamous non-small cell lung cancer (NSCLC) whose disease progresses after first-line chemotherapy are limited. This randomized, open-label, international phase 3 study evaluated efficacy and safety of nivolumab versus docetaxel in this patient population af...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Borghaei, Hossein, Paz-Ares, Luis, Horn, Leora, Spigel, David R., Steins, Martin, Ready, Neal E., Chow, Laura Q., Vokes, Everett E., Felip, Enriqueta, Holgado, Esther, Barlesi, Fabrice, Kohlhäufl, Martin, Arrieta, Oscar, Burgio, Marco Angelo, Fayette, Jérôme, Lena, Hervé, Poddubskaya, Elena, Gerber, David E., Gettinger, Scott N., Rudin, Charles M., Rizvi, Naiyer, Crinò, Lucio, Blumenschein, George R., Antonia, Scott J., Dorange, Cécile, Harbison, Christopher T., Finckenstein, Friedrich Graf, Brahmer, Julie R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705936/
https://ncbi.nlm.nih.gov/pubmed/26412456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1507643
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados